More solutions are entering the market with the goal of identifying patients at risk for opioid use disorder, improving prescribing practices, and enhancing patient care. But are they meeting providers’ needs? KLAS’ Jackson Tate takes a closer look.
There’s no way around it; diverse patient populations need diverse ways of interacting and engaging with providers. The sooner we accept that and make it happen, the better we’ll all be, says CMIO Michael Marino.
A number of topics seemed to bubble up to the surface during our most popular interviews from the past year, but perhaps none were as prominent as digital health, the advancement of women in IT leadership roles, and addressing opioid abuse.
Although legislative efforts to fund opioid reduction programs are critical, the real difference is being made at the local level, says Jackson Tate, who discusses the findings from KLAS’ recent study.
Whether it’s through sharing best practices for reducing opioid prescriptions or building a more effective benchmarking program, the goal of every CHIME initiative is the same: to make an impact, says CEO Russ Branzell.